Clinical Trials Logo

Coronary Artery Lesions clinical trials

View clinical trials related to Coronary Artery Lesions.

Filter by:
  • None
  • Page 1

NCT ID: NCT04573660 Recruiting - Clinical trials for Acute Myocardial Infarction

Abbott Vascular Medical Device Registry

AV-MDR
Start date: October 25, 2020
Phase:
Study type: Observational

The AV-MDR is a prospective, non-randomized, open-label, multi-center registry. The purpose of the AV-MDR study is to proactively collect and evaluate clinical data on the usage of the devices in scope within their intended use with the aim of confirming safety and performance throughout their expected lifetime, ensuring the continued acceptability of identified risks, detecting emerging risks on the basis of factual evidence, ensuring the continued acceptability of the benefit-risk ratio, and identifying possible systematic misuse or off-label usage such that the intended use can be verified as appropriate.

NCT ID: NCT03218787 Completed - Clinical trials for Coronary Artery Lesions

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Start date: July 19, 2017
Phase: N/A
Study type: Interventional

XIENCE 90 study is a prospective, single arm, multi-center, open label trial to evaluate the safety of 3-month dual antiplatelet therapy (DAPT) in subjects at high risk of bleeding (HBR) undergoing percutaneous coronary intervention (PCI) with the approved XIENCE family of coronary drug-eluting stents. The XIENCE family stent systems include commercially approved XIENCE Xpedition Everolimus Eluting Coronary Stent System (EECSS), XIENCE Alpine EECSS, XIENCE PRO^X EECSS [rebrand of the XIENCE Xpedition Stent System and is only available outside of the United States (OUS)], XIENCE PRO^A EECSS (rebrand of the XIENCE Alpine Stent System and is only available OUS) and XIENCE Sierra EECSS of coronary drug-eluting stents.

NCT ID: NCT01972022 Active, not recruiting - Clinical trials for Coronary Artery Lesions

TRANSFORM OCT TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer With Optical Coherence Tomography

TRANSFORM
Start date: November 2013
Phase: Phase 4
Study type: Interventional

First prospective randomized controlled study to evaluate in an 'all-comers' population with coronary artery disease whether treatment with a novel everolimus eluting stent (EES) with a biodegradable polymer is superior to a durable polymer zotarolimus eluting stent (ZES), with respect to the long term vascular response to treatment These data are important to ascertain the superiority of a new generation DES with bioabsorbable polymer coating to reduce the long term development of in-stent neoatherosclerosis.

NCT ID: NCT00967902 Completed - Clinical trials for Coronary Artery Lesions

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

REMEDEE
Start date: November 2009
Phase: Phase 2
Study type: Interventional

To demonstrate the safety and effectiveness of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) compared to the Taxus® Liberté® Stent in the treatment of coronary artery lesions.